Followers | 1 |
Posts | 70 |
Boards Moderated | 0 |
Alias Born | 02/27/2019 |
Tuesday, February 25, 2020 1:38:51 PM
a. The first amortization payment is due in the amount of $110,000, payable in cash, or alternatively, in shares.
b. Exactus becomes liable for paying Liquidated Damages to the Note Holders, since their S-1 was not declared effective in the 90 days following the Note issuance.
I know you guys here are more interested in share price, and how it would be effected by the Note payments and liquidated damages being due. (I, on the other hand am more interested in the underlying business.) In my view, it is too early to tell. Without much disclosure on the financial state of the company - what are the revenue streams from the harvest, have they made the Note payment in cash or in shares, etc. - we cannot say much.
If the payment was made in shares, that means dilution. However, without the S-1 being effective the Note holders cannot sell easily and cannot put downward pressure on the share price (for now).
Finally, I have no information on the identity of the Note holder(s), and have no idea whether they are in Brooklyn or not. Maybe you can share whatever info you have.
Cheers,
K
Recent PLSH News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 03:28:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 07:24:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/08/2023 08:04:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 05:07:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:15:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 04:21:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 03:28:18 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 03:19:11 PM
- Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast • InvestorsHub NewsWire • 07/18/2023 04:41:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 01:00:13 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM